Companion of the mobility impaired

Mastering complex technologies to simply walk

Today our exo walks in clinical trials

In 2018 in Rehab Centers in Europe and overseas

Soon a personal version to accompany your activities of daily living, at home and in the city



Olivier 00


During the 2017 clinical trials, persons with complete SCI have walked with our exo, without crutches.

Floriane chair long
Sandy thumbs up
After the first steps

I will probably never forget the emotion of these first steps...

Françoise First patient in clinical trials



3 technology disruptions to emulate natural walk

First usage of dynamic robotics algorithms in an exoskeleton. Successful technological bet to mimic human walk

First exo capable of replicating the motions of the human body. 12 actuated joints, commanded by super fast electronics

First intuitive control system. Miniaturized inertia units understand the user’s intent via her torso motion

This leading edge technology has one purpose : to allow mobility impaired persons to walk again, pass obstacles and lead an ordinary life again

+15 Awards and distinctions

With three victories in the Global Innovation Award and Digital Innovation Award of BPIFrance

Benefits for


1 day of autonomy in typical use
2 hours of battery life in continuous walk

Benefits in autonomy and therapeutics

We work with physicians for patients

Nicolas Simon President, Wandercraft

3 million potential users with our current technology

Enabling medical personnel to propose better treatments

Managed by expert physicians and physiotherapists, clinical trials will be researching therapeutical benefits of natural walk for digestion, cardiovascular condition, bone density and neuromuscular mobilization


Walking, hands-free

And standing up, turning, sitting down, soon walking over curbs, stairways, getting around at home, going to work, stepping into a vehicle

Allowing you to do the activities of daily living

Developed for

Many pathologies

Our current technology is adapted to wheelchair users with a good control of their torso. We started trials with SCI patients

We will soon accommodate some neuromuscular diseases and hemiplegia

Validating technology through

Clinical trials

With expert physicians and physiotherapists to validate the exo’s safety and performances and research benefits for patient health

The first trials were completed in 2017 with SCI patients, near Paris and in the Rehabilitation Center of Pionsat, in the center of France.

Their aim was to validate the exo’s ability to stand up, walk and sit down with its user safely, autonomously, without crutches

In 2018, several clinical studies are planned in large healthcare centers specializing in physical medicine and rehabilitation

They will contribute to improving performances and researching the impacts on patient health

We owe a lot to Francoise, Jeremy, Bernard, Sandy, Arnaud, Virginie, Floriane, Olivier, Thierry and Alain, our first trial patients, for the enthusiasm and the energy they give us !

Sandy - I feel tall

I am tall, finally...

Sandy Fourth testing patient

1st clinical trials February 2017

We are the center of an


We work with physicans and scientists. We develop with our users

Prs Laffont, Boyer and Yelnik with Jeremy in self-balancing trial

Medical Committee

Validating our medical approach

Recognized experts in Physical Medicine and Rehabilitation (PMR) supervise our development

Three prominent physical medicine and readaptation specialists, Professors Isabelle Laffont, Alain Yelnik and François Boyer, have agreed to head our scientific committee

We work with many physicians and physios specialized in PMR, neurology and orthopaedics

Nicolas, Jesse and Aaron with HZD walk simulator

Robotics ecosystem

Increasing our technological advantage

We leverage the work of the best academics in dynamic walk robotics

Professor Nicolas Petit, director of the Centre Automatique et Systèmes at MinesParisTech, chairs our Robotics Scientifc Committe since our first steps

We work closely with Professors Jesse Grizzle at University of Michigan and Aaron Ames in Caltech

Dorine with her aerobatics aircraft

User Committee

Putting technology at the service of users

Dorine Bourneton, aerobatics champion and with SCI and Jonathan Farjon, scientist in Centre National de la Recherche Scientifique with a CMT disease, head our User Committee

They are joined by our clinical trials test patients

Jeremy debrief

Patient associations

Better understanding needs

Patient associations help us adapt our technology to user needs

We work with Association Française contre les Myopathies, CMT-France, Amis FSH and other organizations